At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-site, Open-Label, Parallel-Group Study To Evaluate Changes In Tobacco-Related Biomarkers of Exposure and Biomarkers of Potential Harm With Use of Heated Tobacco Products Compared to Combustible Cigarettes in Adult Smokers
In Brief
A clinical study evaluating Ploom HTP Menthol HTS; MX3 (681), Ploom HTP Tobacco HTS; R8 (120), and 2 other interventions for Tobacco Use. Completed, enrolled 921 participants across 8 sites.
Detailed Summary
The purpose of the study is to evaluate changes in biomarkers of exposure (BoE) to harmful and potentially harmful constituents (HPHCs) in adult smokers who completely switch to Ploom heated tobacco products (HTPs) compared to those who continue to smoke usual brand combustible cigarettes (UBCC).
Study Details
Timeline
Interventions
Menthol heated tobacco product
Non-menthol heated tobacco product
No smoking or other tobacco product use for duration of the study, menthol group comparator
No smoking or other tobacco product use for duration of the study, non-menthol group comparator